Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Phase II Trial to Compare Treosulfan-based Conditioning Therapy With Busulfan-based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) in Paediatric Patients With Non-malignant Diseases

NCT02349906 is registered in ClinicalTrials.gov with medac GmbH as lead sponsor.

NCT NCT02349906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02349906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Phase II Trial to Compare Treosulfan-based Conditioning Therapy With Busulfan-based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) in Paediatric Patients With Non-malignant Diseases
Lead sponsor
medac GmbH
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2015
Completion date
February 13, 2023
Enrollment
106 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

bone marrow failure syndromes, haemoglobinopathies, inborn errors of metabolism, primary immunodeficiencies